Search by Drug Name or NDC

    NDC 65086-0001-12 Verkazia 1 mg/mL Details

    Verkazia 1 mg/mL

    Verkazia is a OPHTHALMIC; TOPICAL EMULSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Santen Incorporated. The primary component is CYCLOSPORINE.

    Product Information

    NDC 65086-0001
    Product ID 65086-001_0789796b-2f2d-f754-e063-6294a90a5663
    Associated GPIs 86720020001630
    GCN Sequence Number 080149
    GCN Sequence Number Description cyclosporine DROPERETTE 0.1 % OPHTHALMIC
    HIC3 Q2C
    HIC3 Description OPHTHALMIC ANTI-INFLAMMATORY IMMUNOMODULATOR-TYPE
    GCN 46848
    HICL Sequence Number 004524
    HICL Sequence Number Description CYCLOSPORINE
    Brand/Generic Brand
    Proprietary Name Verkazia
    Proprietary Name Suffix n/a
    Non-Proprietary Name cyclosporine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form EMULSION
    Route OPHTHALMIC; TOPICAL
    Active Ingredient Strength 1
    Active Ingredient Units mg/mL
    Substance Name CYCLOSPORINE
    Labeler Name Santen Incorporated
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA214965
    Listing Certified Through 2024-12-31

    Package

    NDC 65086-0001-12 (65086000112)

    NDC Package Code 65086-001-12
    Billing NDC 65086000112
    Package 24 POUCH in 1 CARTON (65086-001-12) / 5 VIAL, SINGLE-DOSE in 1 POUCH / .3 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2022-02-01
    NDC Exclude Flag N
    Pricing Information N/A